 |
Minimal deposit $50 Exclusive promotion |
Our score |
0% commission |
Are you looking to buy Synthetic Biologics stocks? Chech our BAMagazine with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy AMEX:SYN! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Synthetic Biologics stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Synthetic Biologics, Inc., a clinical-stage company develops therapeutics to treat gastrointestinal diseases in the United States. Its lead product candidates include SYN-004 that has completed Phase II clinical trial designed to degrade commonly used intravenous beta-lactam antibiotics in gastrointestinal tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic organisms, the emergence of antimicrobial resistance (AMR), and acute graft-versus-host-disease in allogeneic hematopoietic cell transplant recipients. The company is also developing SYN-010 that is in Phase IIb/III clinical trial to reduce the impact of methane-producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation; and SYN-020, an early-stage oral formulation for the enzyme intestinal alkaline phosphatase to treat both local GI and systemic diseases. In addition, its clinical stage products include SYN-006 and SYN-007 for the prevention of CDI, overgrowth of pathogenic organisms, and AMR; and SYN-005 for the prevention and treatment of pertussis. Synthetic Biologics, Inc. has collaborations with Intrexon Corporation, The University of Texas at Austin, and Cedars-Sinai Medical Center; and a clinical trial agreement with Washington University School of Medicine in St. Louis to conduct a Phase 1b/2a clinical trial of SYN-004. The company is headquartered in Rockville, Maryland.
Average volume
31.49 million shs
MARKET CAP
$19.99 million
Stock exchange
NYSEAMERICAN
Buy this stock!
- Stephen Johnson
- July 20, 2021
- No Comments
How to buy Synthetic Biologics stocks?
Below is a quick guide on how to buy AMEX:SYN stocks safe, fast and around the world in less than five minutes.
Step 1: Open an account with eToro – eToro is the best broker to buy Synthetic Biologics shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Step 2: Upload your ID – As per KYC regulations eToro will ask you to upload a copy of your passport or driver’s license.
Step 3: Deposit Funds – Deposit some money into your newly created eToro account. You can choose between wire transfer, e-wallet or debit/credit card or Paypal.
Step 4: Buy Synthetic Biologics – Search for “”AMEX:SYN”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Synthetic Biologics stocks with 0% commission!.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
Is Synthetic Biologics a buy right now?
2 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Synthetic Biologics in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” Synthetic Biologics stock.
What stocks does BAMagazine like better than Synthetic Biologics?
Wall Street analysts have given Synthetic Biologics a “Buy” rating, but there may be better short-term opportunities in the market. Some of BAMagazine’s past winning trading ideas have resulted in 5-15% weekly gains. BAMagazine just released five new trading ideas, but Synthetic Biologics wasn’t one of them. BAMagazine thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
2 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
3 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
How to buy Synthetic Biologics stocks step by step guide
It can be difficult to navigate through all the outdated and incorrect information related to purchasing AMEX:SYN stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Synthetic Biologics stocks with a step by step approach.
Step 1: Open an Account with a Broker
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Synthetic Biologics stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Step 2: Verify your Account
Because eToro is a regulated platform, you’ll need to complete the KYC process, this is standard practice and only takes a couple of minutes. You’ll need to provide a photo ID (passport, driving licence) and proof of address (utility bill, bank statement).
Step 3: Fund your eToro Account
Once you’ve signed up and verified your account, you’ll need to deposit funds. eToro accepts credit/debit cards, bank transfers, and also e-wallets. So whatever your preference there will be something for you.
Step 4: Search for Synthetic Biologics stocks
Now that you’ve funded your eToro account, just type “AMEX:SYN stocks” into the search bar at the top of the screen and press “trade”.
Step 5: Buy AMEX:SYN
All that’s left is to buy some AMEX:SYN stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
How And Where To Buy Stocks Conclusion
All in all, AMEX:SYN is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Synthetic Biologics stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
When is Synthetic Biologics’ next earnings date?
Synthetic Biologics is scheduled to release its next quarterly earnings announcement on Thursday, February 18th 2021.
View our earnings forecast for Synthetic Biologics.
How were Synthetic Biologics’ earnings last quarter?
Synthetic Biologics, Inc. (NYSEAMERICAN:SYN) released its quarterly earnings results on Tuesday, November, 10th. The company reported ($0.14) earnings per share (EPS) for the quarter.
View Synthetic Biologics’ earnings history.
How has Synthetic Biologics’ stock price been impacted by COVID-19?
Synthetic Biologics’ stock was trading at $0.36 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SYN shares have increased by 155.6% and is now trading at $0.92.
When did Synthetic Biologics’ stock split? How did Synthetic Biologics’ stock split work?
Synthetic Biologics’s stock reverse split on the morning of Monday, August 13th 2018. The 1-35 reverse split was announced on Wednesday, August 1st 2018. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 10th 2018. An investor that had 100 shares of Synthetic Biologics stock prior to the reverse split would have 3 shares after the split.
Where to Buy Synthetic Biologics Stocks Broker Reviews
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying AMEX:SYN stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
- eToro takes pride in keeping their customers safe, they follow strict data protection rules to keep access to sensitive information to a minimum. Any of the information you provide eToro is even protected by SSL encryption, this ensures that even if someone were to gain access to the servers all your data remains safe.
Over 95% of client funds are kept offline, in cold storage, which is crucial for any broker that manages your assets. Regardless of how secure a platform is meant to be, we recommend using 2FA to add an additional layer of security to your account.
Excellent for both new and experienced traders
eToro offers users a range of features to start investing as quickly as possible. They have a relatively unique feature called copy trading, which lets you earn a passive income by mirroring experienced traders, this allows you to start earning profit quickly, and gives you a better understanding of the strategies used by professionals. Additionally, eToro allows users to invest in managed portfolios, a managed portfolio being a variety of similar assets grouped together, allowing you to diversify your account, reducing any potential risk. For those with previous trading experience, you can invest in markets outside of stocks, as eToro allows users to trade ETFs, commodities, crypto and indices. If you already invest outside of the stock market space this can be very useful, as it allows you to manage all your investments in just one place.
What price target have analysts set for SYN?
2 Wall Street analysts have issued 12 month target prices for Synthetic Biologics’ stock. Their forecasts range from $1.25 to $1.50. On average, they expect Synthetic Biologics’ stock price to reach $1.38 in the next twelve months. This suggests a possible upside of 49.5% from the stock’s current price.
View analysts’ price targets for Synthetic Biologics or view top-rated stocks among Wall Street analysts.
Are investors shorting Synthetic Biologics?
Synthetic Biologics saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 1,810,000 shares, an increase of 565.4% from the December 31st total of 272,000 shares. Based on an average trading volume of 11,400,000 shares, the days-to-cover ratio is currently 0.2 days.
View Synthetic Biologics’ Short Interest.
Compliance
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
Who are Synthetic Biologics’ key executives?
Synthetic Biologics’ management team includes the following people:
Mr. Steven A. Shallcross CPA, CEO, CFO, Treasurer, Corp. Sec. & Director (Age 60, Pay $989.81k)
Vincent I. Perrone, Director of Corp. Communication
Dr. Vince Wacher, Head of Product and Corp. Devel.
Dr. Michael Kaleko, Sr. VP of R&D
Ms. Lara M. Guzman, Sr. Director of Project Operations
Who are some of Synthetic Biologics’ key competitors?
Some companies that are related to Synthetic Biologics include Aeterna Zentaris (AEZS), Elite Pharmaceuticals (ELTP), Vaccinex (VCNX), Mereo BioPharma Group (MREO), CannTrust (CNTTF), Catabasis Pharmaceuticals (CATB), CV Sciences (CVSI), Iterum Therapeutics (ITRM), Celsion (CLSN), Acerus Pharmaceuticals (ASPCF), Trevi Therapeutics (TRVI), CNS Pharmaceuticals (CNSP), Regulus Therapeutics (RGLS), Appili Therapeutics (APLIF) and Pulmatrix (PULM).
View all of SYN’s competitors.
What other stocks do shareholders of Synthetic Biologics own?
Based on aggregate information from BAMagazine, some companies that other Synthetic Biologics investors own include Synergy Pharmaceuticals (SGYP), Tonix Pharmaceuticals (TNXP), Agenus (AGEN), Palatin Technologies (PTN), Rigel Pharmaceuticals (RIGL), Sorrento Therapeutics (SRNE), CorMedix (CRMD), Idera Pharmaceuticals (IDRA), Ampio Pharmaceuticals (AMPE) and Navidea Biopharmaceuticals (NAVB).
What is Synthetic Biologics’ stock symbol?
Synthetic Biologics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol “SYN.”
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
Who are Synthetic Biologics’ major shareholders?
Synthetic Biologics’ stock is owned by a number of institutional and retail investors. Top institutional shareholders include Fisher Asset Management LLC (0.63%). Company insiders that own Synthetic Biologics stock include Randal J Kirk and Steven A Shallcross.
View institutional ownership trends for Synthetic Biologics.
Which major investors are buying Synthetic Biologics stock?
SYN stock was acquired by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC.
View insider buying and selling activity for Synthetic Biologics or or view top insider-buying stocks.
How do I buy shares of Synthetic Biologics?
Shares of SYN can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Interactive Brokers Review, eToro Review, DEGiro Review, AvaTrade Review, IG Markets Review, IC Markets Review, CMC Markets Review, Admiral Markets Review and many more. Read one of the reviews to find out everything about the broker and start buying stocks now.
What is Synthetic Biologics’ stock price today?
One share of SYN stock can currently be purchased for approximately $0.92.
How much money does Synthetic Biologics make?
Synthetic Biologics has a market capitalization of $18.39 million.
How many employees does Synthetic Biologics have?
Synthetic Biologics employs 11 workers across the globe.
More information
At BAMagazine.com we want to make sure that you have all the most relevant information about buying stocks. We bring you the best guides about the stock market with personal reviews, background information, platform reviews, how to’s and more. Want to get other information? Then check out the OTC stocks, NASDAQ stocks, NYSE stocks, LON stocks, FRA stocks, ETR stocks, EPA stocks, TSX stocks or Amex stocks. Looking for more detailed info like 5g stocks, biotech stocks, gold stocks and other information out of our reportlab.
Frequently asked questions
How can you buy Synthetic Biologics stock on the internet?
You can easily buy Synthetic Biologics stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Another option is using a regulated broker like IC Markets or Interactive Brokers. You can an account with these brokers and start buying or trading AMEX:SYN stocks in a safe and complete environment to trade in.
Where to buy Synthetic Biologics stock?
You will first want to find a licensed broker that supports AMEX:SYN stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading AMEX:SYN stocks in a safe and complete environment.
Is AMEX:SYN stock a good investment?
As with any other asset, there is an element of risk associated with buying AMEX:SYN stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Synthetic Biologics stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with AMEX:SYN is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Synthetic Biologics stock.
How do you trade Synthetic Biologics stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Synthetic Biologics stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on AMEX:SYN stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Synthetic Biologics stock?
To sell your AMEX:SYN stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Synthetic Biologics stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading AMEX:SYN stock.
Share this information
Share on facebook
Facebook
Share on twitter
Twitter
Stephen Johnson
Stephen knows a lot about financial products and in particular has a great passion for the stock markets and its participants. We hope that the information provided will help you. Something not quite clear? Please leave your questions or comments at the bottom of the page.
| Our score ★★★★★ | |
| Our score ★★★★★ | |
| Our score ★★★★★ |
Newsletter
Recent News
Table of Contents
| |
Our score |
0% commission |
Other stocks
Related News
All EPA Stocks More Information EPA stocks What Is the Paris Stock Exchange (EPA)? Now
November 16, 2021
No Comments
English 
Svenska 
Dansk 
Nederlands 
Suomi 
Eesti 
日本語